PRUNUS Therapeutics logo — Sustainable therapeutics via synthetic biology

PRUNUS Therapeutics

Sustainable therapeutics via synthetic biology

Founded 2016 United States Chicago, United States 1 employees Biotechnology, Health Care +1

General Information

Company Name PRUNUS Therapeutics
Founded Year 2016
Location United States Chicago, United States
Employees 1
Industries Biotechnology, Health Care, Pharmaceutical
Social

BounceWatch is an independent company data service, not affiliated with PRUNUS Therapeutics. To contact PRUNUS Therapeutics, visit prunustx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does PRUNUS Therapeutics compare?

A PDF of PRUNUS Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting PRUNUS Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About PRUNUS Therapeutics

PRUNUS Therapeutics is a biotechnology startup that focuses on sustainable therapeutics via synthetic biology. Founded in 2016, the company's main platform is dedicated to the discovery and development of innovative therapeutics and diagnostics for human and animal healthcare, with a specific emphasis on sustainable cancer treatment. The company operates within the Biotechnology, Health Care, and Pharmaceutical industries.

As of now, details about the company's headquarters and its last investment are not available. PRUNUS Therapeutics presents an intriguing investment opportunity for venture capital firms interested in supporting groundbreaking advancements in the field of synthetic biology and sustainable healthcare.

Business keywords: synthetic biology, therapeutics, diagnostics, preclinical stage, immuno-oncology, small molecules, cancer immunotherapy

No funding data available for PRUNUS Therapeutics yet.

PRUNUS Therapeutics Alternatives & Competitors

PRUNUS Therapeutics vs
IDEAYA Biosciences
IDEAYA Biosciences United States

Synthetic lethality precision medicine oncology company pursuing– an emerging class of precision med...

Post-IPO Equity
264 employees
Biotechnology, Health Care
PRUNUS Therapeutics vs

We are a synthetic biology company developing a platform to industrialize and scale the microbiome.

Seed
22 employees
AI, Biotechnology
PRUNUS Therapeutics vs
Strand Therapeutics
Strand Therapeutics United States

Where synthetic biology meets RNA therapeutics

Series A
121 employees
Biotechnology, Health and Wellness

FAQ About PRUNUS Therapeutics

Sustainable therapeutics via synthetic biology
PRUNUS Therapeutics was founded in 2016.
PRUNUS Therapeutics is headquartered in Chicago, United States.
PRUNUS Therapeutics operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on synthetic biology, therapeutics, diagnostics and preclinical stage.
PRUNUS Therapeutics has approximately 1 employees.
Top alternatives and competitors to PRUNUS Therapeutics include IDEAYA Biosciences, Persephone Biosciences, Strand Therapeutics, Vividion Therapeutics, Inc., Encuragen. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PRUNUS Therapeutics and IDEAYA Biosciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for PRUNUS Therapeutics, https://bouncewatch.com/company/prunus-therapeutics, updated 19 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes